This page contains all the post-entry conditions for each commodity on In Vitro’s import permits.
Please locate the permit and commodity/ies relevant to your products, as provided on your quote, and review the associated conditions.
Ensure your proposed use of the product complies with the relevant condition/s.
Click on the relevant permit number to take you to the permit and then click on the commodity to expand the End Use Conditions relevant to each commodity.
Valid from 1 June 2025 to 1 June 2029
END USE CONDITIONS
Additional post entry conditions
Department of Health, Disability and Ageing import conditions for Francisella tularensis subsp. novicida:
Department of Health, Disability and Aging advice to importers and end users for Francisella tularensis subsp. novicida:
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
Valid from 1 April 2025 to 5 March 2029
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
Valid from 1 April 2025 to 8 February 2028
END USE CONDITIONS
END USE CONDITIONS
Additional End Use Conditions
Department of Health and Aged Care - Import Conditions
Department of Health and Aged Care - Advice to Importers and End-users
END USE CONDITIONS
END USE CONDITIONS
Additional End Use Conditions
Department of Health and Aged Care - Advice to Importers and End-users
Any microorganisms or infectious agents (including derivatives) within the goods must not be used for the synthesis of replication-competent microorganisms or infectious agents.
Department of Health and Aged Care advice to End Users - Advice to End-users of Plasmodium falciparum
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
Valid from 31 March 2025 to 25 June 2029
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
Additional End Use Conditions
Department of Health and Aged Care end use conditions
All diagnostic samples and human derived materials contained within the goods must be handled using standard precautions as outlined in the Australian Guidelines for the Prevention and Control of Infection in Healthcare, as published on the National Health and Medical Research Council website.
Department of Health and Aged Care – Advice to importers and end users
A risk assessment must be undertaken to ensure that any specific hazards depending on the particular end use are identified and managed.
Valid from 31 March 2025 to 20 December 2028
END USE CONDITIONS
Additional End Use Conditions
Dengue virus
Leishmania spp, Influenza B and Mycoplasma genitalium
Department of Health and Aged Care advice to End Users
Dengue virus
Influenza B virus
Leishmania spp and Mycoplasma genitalium
END USE CONDITIONS
Additional End Use Conditions
Zika virus
Department of Health and Aged Care advice to End Users
Zika Virus
END USE CONDITIONS
Additional End Use Conditions
Department of Health and Aged Care advice to End Users
END USE CONDITIONS
Additional End Use Conditions
Department of Health and Aged Care advice to End Users
END USE CONDITIONS
END USE CONDITIONS
END USE CONDITIONS
* Synthesis of replication-competent microorganisms, infectious agents or homologues refers to the process of modifying or constructing microorganisms and infectious agents which can replicate within eukaryotic or prokaryotic cells.
END USE CONDITIONS
Synthesis* of replication competent microorganisms, infectious agents or homologues from the goods is restricted to plasmids that are non-conjugative and non-integrative, and not made for the purpose of creating/transcribing or expressing a separate replication competent infectious agent.
* Synthesis of replication-competent microorganisms, infectious agents or homologues refers to the process of modifying or constructing microorganisms and infectious agents which can replicate within eukaryotic or prokaryotic cells.